EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)

Dvir Gatt iD, Isaac Martin, Rawan AlFouzan, Theo J Moraes iD

Pathogens · 17.01.2023 · 12 (2) · 154

DOI: 10.3390/pathogens12020154 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 17.01.2023. Verfasst von Dvir Gatt und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Medicine, Department of Pediatrics, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada. Die Arbeit wurde bisher 118-mal zitiert (Crossref) und nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract disease, especially in young children. Despite its global impact on healthcare, related to its high prevalence and its association with significant morbidity, the current therapy is still mostly supportive. Moreover, while more than 50 years have passed since the first trial of an RSV vaccine (which unfortunately caused enhanced RSV disease), no vaccine has been approved for RSV prevention. In the last two decades, our understanding of the pathogenesis and immunopathology of RSV have continued to evolve, leading to significant advancements in RSV prevention strategies. These include both the development of new potential vaccines and the successful implementation of passive immunization, which, together, will provide coverage from infancy to old age. In this review, we provide an update of the current treatment options for acute disease (RSV-specific and -non-specific) and different therapeutic approaches focusing on RSV prevention.

Schlagwörter

Stichwörter der Autor:innen

antiviralbronchiolitismonoclonal antibodiesrespiratory syncytial virusvaccine

Autor:innen und Institutionen

  • Division of Respiratory Medicine, Department of Pediatrics, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.
  • Program in Translational Medicine, Hospital for Sick Children, Toronto, ON M5G 1X8, Canada.

ORCID-Profile: Dvir Gatt, Theo J Moraes

Zitieren

APA

Gatt, D., Martin, I., AlFouzan, R., & Moraes, T. J. (2023). Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV). Pathogens, 12(2), 154. https://doi.org/10.3390/pathogens12020154

Vancouver

Gatt D, Martin I, AlFouzan R, Moraes TJ. Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV). Pathogens. 2023;12(2):154. doi:10.3390/pathogens12020154

BibTeX
@article{Gatt2023,
  author = {Gatt, Dvir and Martin, Isaac and AlFouzan, Rawan and Moraes, Theo J},
  title = {Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)},
  journal = {Pathogens},
  year = {2023},
  volume = {12},
  number = {2},
  pages = {154},
  doi = {10.3390/pathogens12020154}
}
Kostenlos starten →